{
    "type": "ETP",
    "ucits": false,
    "leverage": true,
    "derivatives": false,
    "swaps": false,
    "inverse": true,
    "replication_method": "physical",
    "complex_factors": [
        "Inverse Exposure",
        "Daily Compounding Effect",
        "High Risk Profile"
    ],
    "classification": "complex",
    "supporting_data": "The Leverage Shares -1x Short JPMorgan ETP is classified as complex primarily due to its inverse exposure and the compounding effect resulting from daily rebalancing. The KIID explicitly states that the product is not simple and may be difficult to understand, which is a strong indicator of complexity under MiFID II. The ETP aims to provide -1 times the daily performance of JPMorgan Chase & Co. stock, which introduces a level of complexity that retail investors may struggle to comprehend fully. Additionally, the high-risk profile (risk indicator 6 out of 7) and the warning that the product is intended for sophisticated investors further support this classification. The compounding effect, which can lead to unexpected returns over longer holding periods, adds another layer of complexity. While the replication method is physical, the inverse nature and the risks associated with shorting and daily rebalancing make this a complex product.",
    "confidence": 90,
    "counter_argument": "One might argue that the product uses physical replication and does not employ derivatives or swaps, which could suggest a non-complex classification. However, the inverse exposure and the compounding effect introduce significant complexity that outweighs the simplicity of physical replication. The product's high-risk profile and the explicit warnings about its suitability only for sophisticated investors further justify the complex classification.",
    "risk_level": "high",
    "comprehension_warning": true
}